Running Boltz-2 inference at scale in Nebius

AI foundation models, specifically Boltz-2, are revolutionizing drug discovery by rapidly predicting molecular interactions with disease-related proteins, significantly enhancing the speed and accuracy of identifying potential therapeutic compounds. Boltz-2 achieves near-experimental accuracy at a fraction of the computational cost of traditional methods, allowing high-throughput screening of hundreds of thousands of compounds per day when used in high-performance computing environments. The model's integration into Nebius AI Cloud utilizes Managed Kubernetes to orchestrate GPU resources and shared filesystems, facilitating efficient, large-scale biomolecular inference. This setup supports the entire drug discovery pipeline from hit discovery to lead optimization by enabling rapid, scalable, and cost-effective simulations. The framework described includes the deployment of Boltz-2 in a secure, compliant cloud environment, emphasizing the importance of efficient data management and workflow orchestration to support intensive drug discovery workloads.

No tracked trend matches for this post yet.

Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.